Health and Fitness Health and Fitness
Wed, July 8, 2009
Tue, July 7, 2009
Mon, July 6, 2009
Fri, July 3, 2009
Thu, July 2, 2009
Wed, July 1, 2009
Tue, June 30, 2009

Diagnos Inc.: DIAGNOS Inc.: Sale of a Gold Project to Exploration Lounor


Published on 2009-06-30 06:52:09, Last Modified on 2009-06-30 06:52:38 - Market Wire
  Print publication without navigation


BROSSARD, QUEBEC, CANADA--(Marketwire - June 30, 2009) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announced today the signing of an agreement with Exploration Lounor Inc., based on CARDS' (Computer Aided Resources Detection System) results, on the Nicole property located in the township of Brassani, Val-d'Or mining district, in the Abitibi area of Quebec.

The Nicole property is located east of recent high grade gold discoveries in the Barry-Urban district. In the district, quartz-carbonate veins occur in shear zones, contain magnetite and pyrite, and display biotite and albite alteration. Based on CARDS' results, DIAGNOS generated mineral potential targets for both gold and base metals on the Nicole property. Significant INPUT geophysical anomalies are located near the center of the property. According to the press release by Exploration Lounor Inc., dated June 15th, 2009, the type of INPUT response obtained is often associated with large sulphide lenses, rather than graphite horizons. The property has never been drilled and only ground geophysics (VLF) has been carried out.

Exploration Lounor Inc. has the exclusive option to acquire a 100% interest in the Nicole property by paying DIAGNOS the sum of $15,000 and issuing 100,000 common shares. DIAGNOS will retain a 2% Net Smelter Return (NSR) royalty.

About DIAGNOS

DIAGNOS can count on a multidisciplinary team that includes professionals in geophysics, geology, artificial intelligence, mathematics, information technology, as well as remote sensing and image interpretation.

For further information, please visit our website at [ www.diagnos.com ] or the SEDAR website at [ www.sedar.com ]. You may also contact our investor relations representative.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.


Contributing Sources